Skip to main content

Posts

Showing posts from July 5, 2025

History of Mass Transportation: the FS ALe 582 EMU

  Di Johannes Smit - https://www.flickr.com/photos/johannes-j-smit/3336090235/ , CC BY-SA 2.0,  https://commons.wikimedia.org/w/index.php?curid=112400120 Source: Wikipedia,  https://it.wikipedia.org/wiki/Automotrice_FS_ALe_582 ____

#Coronavirus Disease Research #References (by AMEDEO, July 5 '25)

  Am J Respir Crit Care Med MICHELS EHA, Peters-Sengers H, de Brabander J, Schuurman AR, et al The Plasma Proteome in Community-acquired Pneumonia: Pathophysiology, Outcome and 10-Year Risk. Am J Respir Crit Care Med. 2025 Jul 2. doi: 10.1164/rccm.202502-0325. PubMed           Abstract available Ann Intern Med CROSLEY E, Martin GS In COVID-19 acute hypoxemic respiratory failure, awake prone positioning vs. supine positioning increases survival without intubation. Ann Intern Med. 2025 Jul 1. doi: 10.7326/ANNALS-25-02004. PubMed           Abstract available BMJ COOPER N, Agius S, Freeman K, Church H, et al Impact of physician assistants on quality of care: rapid review. BMJ. 2025;390:e086358. PubMed           Abstract available KIRKLAND A, Greer SL The antivaccine movement threatens health in the US and worldwide. BMJ. 2025;390:r1383. PubMed     ...

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, July 5 '25)

  Biochemistry (Mosc) KAZAKOVA AA, Leonova EI, Sopova JV, Chirinskaite AV, et al Progress in CRISPR/CAS13-Mediated Suppression of Influenza A and SARS-CoV-2 Virus Infection in in vitro and in vivo Models. Biochemistry (Mosc). 2025;90:786-803. PubMed           Abstract available BMC Pediatr XIANG L, Wang Q, Xu Y, Tong Y, et al Paxlovid for the treatment of severe or critical COVID-19 in children. BMC Pediatr. 2025;25:493. PubMed           Abstract available BMJ CHEN C, Zhou W, Cui Y, Cao K, et al Global, regional, and national characteristics of the main causes of increased disease burden due to the covid-19 pandemic: time-series modelling analysis of global burden of disease study 2021. BMJ. 2025;390:e083868. PubMed           Abstract available J Clin Microbiol ROBBINS EM, Bertuzis R, Chiu H-C, Miller L, et al A multicenter study to assess the performance of the p...

Avian #Influenza A(#H5N1) - #Cambodia (#WHO D.O.N., July 5 '25)

  Situation at a glance Between 1 January and 1 July 2025, the World Health Organization (WHO) was notified by Cambodia’s International Health Regulations (IHR) National Focal Point (NFP) of 11 laboratory-confirmed cases of human infection with avian influenza A(H5N1) virus .  Seven of the 11 cases were reported in June , an unusual monthly increase .  Avian influenza A(H5N1) was first detected in Cambodia, in December 2003, initially affecting wild birds.  Since then, 83 cases of human infection with influenza A(H5N1), including 49 deaths (case fatality ratio [CFR] of 59%), have been reported in the country.  While the virus continued to circulate in avian species , no human cases were reported between 2014 and 2022, after which, the virus re-emerged in humans in February 2023.  Since the re-emergence of human A(H5N1) infections in Cambodia in 2023, a total of 27 cases have been reported (six in 2023, 10 in 2024, and 11 to date in 2025), of which 12 were f...